IP Library Granted Patent US 7,297,508
Granted Patent B1
US 7,297,508 · App. 10/681,659 · Granted Nov 20, 2007

Crystallization of fibroblast activation protein alpha (FAPα)

Assignee: Takeda San Diego, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,297,508
App. No.
10/681,659
Granted
Nov 20, 2007
Kind
B1
Abstract

Provided are crystals relating to FAPα and its various uses.

Claims (16)

1. A composition comprising a protein in crystalline form wherein the protein consists of SEQ ID NO:3, and wherein the protein crystal has a crystal lattice in a P2 1 2 1 2 1 space group and unit cell dimensions, +/−5%, of a=70.3 Å b=152.60 Å and c=214.65 Å.

2. A composition according to claim 1 wherein the protein is present in the protein crystal as a dimer.

3. A composition according to claim 1 wherein the protein crystal diffracts X-rays for a determination of structure coordinates to a resolution less than 3.0 Angstroms.

4. A method of obtaining a crystal of SEQ ID NO: 3 comprising:

Forming a crystallization volume comprising a precipitate solution and a protein that consists of SEQ ID NO:3, and wherein the protein crystal has a crystal lattice in a P2 1 2 1 2 1 space group and unit cell dimensions, +/−5%, of a=70.3 Å, b=152.60 Å, and c=214.65 Å; and storing the crystallization volume under conditions suitable for crystal formation until a crystal is formed.

5. A method according to claim 4 wherein the protein is present in the protein crystal as a dimer.

6. A method according to claim 4 wherein the protein crystal diffracts X-rays for a determination of structure coordinates to a resolution less than 3.0 Angstroms.

7. A non-crystalline protein consisting of SEQ ID NO:3.

8. A non-crystalline protein consisting of residues 27-760 of SEQ ID NO:1.

9. The protein according to claim 8 wherein the protein is expressed from a nucleic acid molecule that consists of SEQ ID NO:2.

10. An isolated non-crystalline protein consisting of residues 27-760 of SEQ ID NO:1.

11. An isolated noncrystalline protein consisting of SEQ ID NO:3.

12. A method of obtaining the three-dimensional structure of the protein of SEQ ID NO: 3:

(a) Crystallize a protein consisting of SEQ ID NO: 3 to obtain a protein crystal having a crystal lattice in a P2 1 2 1 2 1 space group and unit cell dimensions, +/−5%, of a=70.3 Å, b=152.60 Å, and c=214.65 Å;

(b) Use the crystal of (a) to obtain an X-ray diffraction pattern; and

(c) Solve the three-dimensional structure of the protein from the diffraction pattern, and thereby obtain the three-dimensional structure.

Assignments (2)
CHANGE OF NAME Recorded Aug 16, 2006
From: SYRX, INC.
To: TAKEDA SAN DIEGO, INC.
Reel/Frame 018132/0496 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 25, 2004
From: AERTGEERTS, KATHLEEN; PRASAD, SRIDHAR; SRIDHAR, VANDENA; WIJNANDS, ROBERT A.; YE, SHENG
To: SYRRX, INC.
Reel/Frame 014668/0642 →
Continuity (1)
Provisional Application 6041733500 · Oct 8, 2002